Chloramphenicol Ear Drops
Brand names: Chloromycetin Ear Drops
Chloramphenicol ear drops are a topical broad-spectrum antibiotic preparation used for bacterial otitis externa.
Adult dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients
- Perforated ear drum
- Myelosuppression during previous exposure to chloramphenicol
- Known personal or family history of blood dyscrasias including aplastic anaemia
Side effects
- Hypersensitivity reactions including angioedema, anaphylaxis, urticaria and fever
- Vesicular and maculopapular dermatitis
- Bone marrow depression
- Aplastic anaemia (rare, reported following topical use of chloramphenicol, with reports of death)
- Blood dyscrasia (occasional)
Interactions
- Avoid concomitant administration with other drugs liable to depress bone marrow function
Clinical monograph
How it works
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, giving a broad-spectrum bacteriostatic effect.
Prescribing in practice
- Hypersensitivity reactions to the drops or their excipients can occur, and the product should be avoided in those with a history of chloramphenicol hypersensitivity.
- Aural toilet to clear debris improves drug contact with the canal in otitis externa.
- Treatment courses are kept short to limit local sensitisation and resistance.
Monitoring
Review the ear clinically for response and watch for local hypersensitivity during treatment.
Counselling the patient
- Use only in the affected ear as prescribed.
- Stop and seek advice if itching, rash or swelling develops.
- Complete the prescribed course and keep the ear dry.
Evidence & guidelines
Topical antibiotics are an established treatment for bacterial otitis externa in UK clinical guidance.
Reference: NICE CKS Otitis Externa; ENT-UK Guidelines for Otitis Externa; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Acute Otitis Media Severity (AOM-SOS) · Otitis Media
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020